Fundraising Overview - The company raised a total of RMB 302,495.13 million by issuing 19,851,367 shares at a price of RMB 152.38 per share, with a net amount of RMB 273,079.07 million after deducting issuance costs [1][19] - As of June 30, 2025, the balance in the fundraising special account was RMB 16,199.4 million, with RMB 94,300 million used for cash management and RMB 57,497.87 million invested in projects [2] Fund Management - The company has established a fundraising management system in compliance with relevant laws and regulations, ensuring dedicated storage and management of the raised funds [3] - A tripartite supervision agreement has been signed with the sponsor and banks holding the fundraising account to ensure proper oversight [4] Fund Usage - The company has not used idle funds for temporary working capital as of June 30, 2025 [6] - The company has approved the use of up to RMB 180,000 million of idle funds for cash management, investing in low-risk financial products with a maturity of no more than 12 months [7][8] - As of June 30, 2025, the balance of idle funds under cash management was RMB 94,300 million [9] Project Investment - The company has not made any pre-investments or replacements for fundraising projects during the reporting period [5] - The company has replaced RMB 10,979.33 million of its own funds with raised funds for project payments [12] - All fundraising projects, including the X-ray source industrialization project and R&D center construction project, have been completed with no surplus funds [12] Changes in Fundraising Projects - There have been no changes or transfers of fundraising projects as of June 30, 2025 [13][14] Compliance and Disclosure - The company has complied with disclosure requirements regarding the management and usage of raised funds, with no violations reported [15]
日联科技集团股份有限公司